Search details
1.
Association of immunosuppression treatment with generalization among patients with ocular myasthenia gravis: A propensity score analysis.
Eur J Neurol
; 29(6): 1805-1814, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35188698
2.
Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis.
Front Immunol
; 13: 895007, 2022.
Article
in English
| MEDLINE | ID: mdl-35874731
3.
Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study.
Neurol Ther
; 11(1): 73-86, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-34729706
4.
Thymectomy and Risk of Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study.
Neurotherapeutics
; 18(4): 2449-2457, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34625864
5.
Melatonin exerts immunoregulatory effects by balancing peripheral effector and regulatory T helper cells in myasthenia gravis.
Aging (Albany NY)
; 12(21): 21147-21160, 2020 11 02.
Article
in English
| MEDLINE | ID: mdl-33136553
6.
Do early prednisolone and other immunosuppressant therapies prevent generalization in ocular myasthenia gravis in Western populations: a systematic review and meta-analysis.
Ther Adv Neurol Disord
; 12: 1756286419876521, 2019.
Article
in English
| MEDLINE | ID: mdl-35173803
7.
Correction to: Thymectomy and Risk of Generalization in Patients with Ocular Myasthenia Gravis: a Multicenter Retrospective Cohort Study.
Neurotherapeutics
; 18(4): 2756, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34750752
Results
1 -
7
de 7
1
Next >
>>